Online Hair Loss Programs: 10 Things to Check Before You Pay

Look for: the product name, its ingredients and strengths, and which of four boxes it sits in: an FDA-approved prescription drug, an approved over-the-counter drug, an off-label use of an approved drug, or a compounded preparation.

Why: the box decides how much review the product has had. The Propecia label says finasteride 1 mg is “indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY.” Oral minoxidil is approved for hypertension, so using it for hair is an “unapproved use of an approved drug.” Compounded preparations are not approved by the FDA, which says it “does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”

Where: the product page, under the price and in the footnotes.

Example: Ro labels each item: “Only oral finasteride (1 mg) is FDA-approved for male pattern baldness,” while its Mane Spray is tagged “Compounded med. Not FDA-approved.” See hair loss treatments and their FDA status.

Verify: FDA’s Drugs@FDA database lists approved human drug products, so you can search the drug name on fda.gov and see whether what you were offered is one of them.

Look for: the standard rate once any introductory period ends, the billing interval, and how many months one charge covers.

Why: “Starting at” is a floor, not a flat rate. Budget with the figure you will pay in month three.

Where: the offer-terms page behind the asterisk beside the price, then the checkout summary.

Example: Hims‘ offer terms say “For monthly subscription plans, the Discount applies to the first month only,” and that the “Standard monthly or multi-month subscription rate resumes after the promotional subscription period.” Its hair-loss prices run from “Starting at $15 per month” to “Starting at $60 per month.” Hers marks every shop-page price “Starting at $X*/mo.” Ro publishes flat prices per plan length instead: oral finasteride is $20 a month quarterly, $18 at six months and $16 at twelve, sold in quarterly shipments, so the first charge covers three months.

Look for: whether the consultation, shipping, provider messaging and follow-ups sit inside the price or are billed on top, and whether free shipping applies only once you are prescribed.

Why: hair-loss treatment is a long stay, so bundled messaging and follow-ups decide what it costs to stay on it.

Where: the “what’s included” block on the product page, and the terms. Our telehealth terms glossary decodes the wording.

Example: Ro lists “Free shipping in discreet packaging” and “Free, unlimited follow-ups with your provider.” Hims lists “Free consultation,” “Free shipping, if prescribed” and “Free, unlimited access to licensed providers.” Hers says “Your treatment will ship to you for free, if prescribed,” and adds that its 5% minoxidil foam does not ship “to Alaska, Hawaii, Puerto Rico, Guam, or military addresses.” No consultation charge appeared on the Hers pages read.

Look for: the medical group behind the clinicians, that your prescriber is licensed where you live, and whether your state allows a questionnaire or requires live video.

Why: HHS’s telehealth guidance is that a clinician must “be licensed or legally permitted to practice in the state where the patient is located.” The format decides how fast you can start.

Where: the consent-to-telehealth document, the notice of privacy practices, and the help center.

Example: Hims’ privacy notice names twelve state entities, among them “You Health of California P.C.” Its support pages say “Depending on the state where you live, your consultation may be conducted asynchronously,” and that “In some states, a video visit with a healthcare provider is required.” The Hers platform FAQ says “Depending on your state, treatment may be determined without a video visit.” Ro’s consent allows “audio, video and/or asynchronous data communications.”

Verify: FSMB’s consumer page says its DocInfo lookup shows, per physician, “Disciplinary actions, License history, Medical school, Type of degree.”

Look for: the pharmacy’s name and state and, for anything compounded, which federal category it falls under.

Why: a preparation compounded by a licensed pharmacist in a state-licensed pharmacy under section 503A of the FD&C Act is exempt from certain federal requirements, including new-drug approval and good manufacturing practice. FDA describes 503B outsourcing facilities as “a category of compounders established in 2013 by the Drug Quality and Security Act,” inspected “according to a risk-based schedule.”

Where: the pharmacy clause in the terms and the dispensing label on the box; detail in our 503A vs 503B guide.

Example: Hims & Hers says it runs “503A compounding pharmacies located in Ohio and Arizona” and acquired “MedisourceRx, a 503B outsourcing facility in California” from September 2024 for sterile compounding. Ro’s terms say prescriptions may be filled by “Roman Health Pharmacy LLC or one of our partner pharmacies” and moved between them “without notice.”

Verify: FDA’s BeSafeRx offers “resources and tools so you can make safer, more informed decisions when purchasing prescription medicine.” NABP lists accredited sites at safe.pharmacy, an “accreditation program for online pharmacies” run since 1999, and keeps a state-board directory: “We partner with our members, the state boards of pharmacy, to protect public health.”

Look for: two lists. The states the company serves, and any products restricted in particular states.

Why: a company can serve your state and still not ship the product you want there.

Where: search the help center for “available” or “states.” If there is no list, email support before starting an intake.

Example: Ro’s help-center article says it is available in all 50 states and Washington D.C. It lists restrictions state by state: Alabama and Mississippi restrict the “Ro 3-in-1 Topical Spray” and “Women’s Hair Loss,” while oral finasteride and minoxidil are not named, and “23 states have at least one restricted offering.” Hims’ terms say the service “is currently only available to individuals who are located in states in which we offer the Service.” No list appeared. Hers says “Not available in all 50 states.”

Look for: how many days before renewal you have to act, which cancellation method works, and whether renewals can be charged early.

Why: the federal ROSCA statute requires an online seller to disclose material terms before taking your billing details and to provide “simple mechanisms for a consumer to stop recurring charges.” The FTC’s 2024 click-to-cancel amendments are not in force; a court vacated them, and the FTC restored the earlier rule on February 12, 2026.

Where: the auto-renewal clause in the terms and the cancellation article in the help center. Calendar it the day you sign up.

Example: Hims and Hers share the wording: a subscription “will automatically renew for another subscription period unless you cancel at least two (2) days before the applicable renewal processing date,” and renewals “may be charged and/or shipped up to two (2) days early.” Hims’ support pages give 48 hours and note that canceling “does not cancel an order that is already processing or has shipped.” Ro fixes no figure: cancel “before the cancelation cutoff date as indicated to you at the time you purchase.”

Look for: three rules: what happens to a partly used period, what happens once the pharmacy has processed your order, and what happens if a clinician declines you.

Why: the third is the one almost nobody looks for, and it decides whether an intake costs you anything if the answer is no.

Where: the refund clause in the terms and the refund article in the help center. Save a copy of both the day you pay.

Example: Ro’s default is that “ANY APPLICABLE FEES AND OTHER CHARGES ARE NOT REFUNDABLE IN WHOLE OR IN PART,” but it commits to an automatic refund if you are “deemed unsuitable for treatment or we reject your treatment request,” and those refunds “may take 5 business days or longer to process.” Hims and Hers both say “We do not offer refunds for partially used subscription periods,” with case-by-case exceptions, and Hims says a refund cannot be guaranteed once the pharmacy has processed an order.

Look for: a named channel for side-effect questions, a stated response time, and a first check-in date.

Why: hair-loss treatment is measured in months, so follow-up is most of what you are buying. The men’s 5% minoxidil label says some men “may need to use this product for at least 4 months before you see results.” FDA’s April 22, 2025 alert on compounded topical finasteride tells consumers to “consult with health care providers and compounders regarding potential risks prior to initiation of treatment.”

Where: the “how it works” or check-in page. If no response time is published, ask support.

Example: Hers publishes the most specific cadence: “Around week two, we’ll check in with you to make sure that everything is going smoothly and that your treatment is a good fit,” plus “unlimited, 24/7 access to your Care Team.” Ro offers “Free, unlimited follow-ups with your provider,” and Hims “Free, unlimited access to licensed providers”; neither publishes a fixed hair-loss check-in interval.

Look for: a BBB profile for the legal entity rather than the brand, a Trustpilot score with its count and date, and any open regulator matter.

Why: scores move and complaint counts are time-boxed, so a number only means something with a date attached.

Where: search the legal name, not the brand, on bbb.org and trustpilot.com, then FDA warning letters on fda.gov and press releases on ftc.gov.

Example: on September 18, 2026, BBB listed Hims & Hers Inc. as “Not Rated,” accredited since February 22, 2018, with 4,456 complaints over three years; Ro at A+, accredited since July 23, 2018. Trustpilot showed 2.9 out of 5 from 9,314 reviews for hims.com, 3.3 from 10,285 for forhers.com and 3.9 from 6,533 for ro.co. The FTC, Utah and California filed a pending lawsuit against Hims & Hers on July 29, 2026 over privacy and billing practices; the company says it is “confident in our position and will vigorously defend ourselves against these baseless claims.” FDA warning letters dated September 9, 2025 concerned compounded semaglutide marketing, not hair loss. We found no FDA or FTC action naming Ro.

Full reviews: Hims, Hers and Ro, on our online hair loss clinics hub. We read these pages on September 18, 2026 and did not order, use or test these services. Our method: how we review.